|
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Supportive Care of Hematopoietic Cell Transplant Patients |
1.25 |
12/03/2019 - 12:00am to 12/03/2020 - 12:00am |
|
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Updates in the Treatment of Follicular Lymphoma and Diffuse... |
1.25 |
11/05/2019 - 12:00am to 11/05/2020 - 12:00am |
|
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Updates in the Treatment of HER-2 Positive Breast Cancer |
1.04 |
10/18/2019 - 12:00am to 10/18/2020 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Advances in Targeted Therapy and Immunotherapy for the Treatment of Kidney Cancer |
1.00 |
02/13/2020 - 12:00am to 02/11/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Current Therapy Options for Graft-Versus-Host Disease |
1.00 |
04/07/2020 - 12:00am to 04/01/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Emerging Strategies for Pediatric Acute Lymphoblastic Leukemia Management |
1.00 |
01/31/2020 - 12:00am to 01/28/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: New Targets and Treatment Options for Acute Myeloid Leukemia |
1.00 |
04/30/2020 - 12:00am to 04/28/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: The Role of the Pharmacist in Smoking Cessation and Education of Patients with Cancer |
1.00 |
06/10/2020 - 12:00am to 06/08/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Updates on the Use of Immunotherapy and Targeted Therapy in Non-Small Cell Lung Cancer |
1.00 |
05/27/2020 - 12:00am to 05/21/2021 - 12:00am |
|
Recorded Presentations from the NCCN 2019 Annual Congress: Hematologic Malignancies™ |
|
11/01/2019 - 1:00pm to 10/31/2020 - 12:00pm |
|
Recorded Presentations from the NCCN 2019 Congress Series™: Lung Cancer |
|
12/17/2019 - 12:00am to 12/17/2020 - 12:00am |
|
Recorded Presentations from the NCCN 2020 Congress Series: Breast Cancer |
|
03/13/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Role of Biomarkers in Individualizing Treatment Selection for Patients with Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Role of Biosimilars in the Oncology Ecosystem |
1.25 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Selection of Optimal First-Line and Maintenance Therapies in Advanced Ovarian Cancer |
1.30 |
07/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward